Abstract: A method for predicting floating times of inclusions during refinements of molten steel includes: predicting a macroscopic multiphase flow field of the molten steel refining, injecting the inclusions into the multiphase flow field uniformly and randomly, determining a capture condition of the inclusions, calculating motion trajectories of the inclusions injected into the multiphase flow field, outputting captured inclusions' information through comparing the motion trajectory of the inclusion and the capture condition, and obtaining an average floating time, a relationship between a removal rate and the floating time, and the complete floating time through analyzing the captured inclusions' information.

Abstract: Disclosed are an image processing method and apparatus, a computer device and a storage medium, which relate to the field of artificial Intelligence. The method includes receiving an original image; performing image photographing defect detection and color deviation detection on the original image, the image photographing defect detection determining whether there exists a photographing defect that is irreparable through image processing, the color deviation detection determining whether there exists color cast in the original image; performing color correction on the original image if the original image passes the image photographing defect detection and does not pass the color deviation detection; and generating a target image based on the color-corrected original image.

Abstract: Provided are compounds of Formula (I): wherein: X is selected from the group of F and Cl; Y is selected from the group of —CH2—, —CH2—CH2—, and —CH(CH3)—; R1 is selected from cycloalkyl, heterocyclyl, aromatic, heteroaromatic, and linear and branched alkyl, alkenyl, and alkynyl chains.

Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.

Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.

Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.

Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.

Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.

Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.

Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.

Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.

Abstract: Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.